In a hypertrophic cardiomyopathy mouse model carrying a Glu180Gly mutation in α-tropomyosin (TM180), disruption of ae3 did not prevent or reverse the hypertrophic phenotype [43]. The gene discussed is SLC4A3; the disease is hypertrophic cardiomyopathy.